FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [RNA-Seq]
RNA-seq (gene expression) · human · 21 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 21 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE292872_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1241797 and SRA study SRP572995. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 3 samples read as cases, 3 as controls.
How we read this: 7 replicated groups read from 21 sample titles; they account for 21 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8867719 Rh4 Clone Cells, ishNTC, Day 7, Rep 1 Rh4 Clone Cells, ishNTC…
- GSM8867720 Rh4 Clone Cells, ishNTC, Day 7, Rep 2 Rh4 Clone Cells, ishNTC…
- GSM8867721 Rh4 Clone Cells, ishNTC, Day 7, Rep 3 Rh4 Clone Cells, ishNTC…
- GSM8867722 Rh4 Clone Cells, ishP3F1, Day 7, Rep 1 Rh4 Clone Cells, ishP3F…
- GSM8867723 Rh4 Clone Cells, ishP3F1, Day 7, Rep 2 Rh4 Clone Cells, ishP3F…
- GSM8867724 Rh4 Clone Cells, ishP3F1, Day 7, Rep 3 Rh4 Clone Cells, ishP3F…
- GSM8867725 Rh4 Clone Cells, ishNTC, Day 2, Rep 1 Rh4 Clone Cells, ishNTC…
- GSM8867726 Rh4 Clone Cells, ishNTC, Day 2, Rep 2 Rh4 Clone Cells, ishNTC…
- GSM8867727 Rh4 Clone Cells, ishNTC, Day 2, Rep 3 Rh4 Clone Cells, ishNTC…
- GSM8867728 Rh4 Clone Cells, ishFANCM_SMC, Day 2, Rep 1 Rh4 Clone Cells, ishFAN…
- GSM8867729 Rh4 Clone Cells, ishFANCM_SMC, Day 2, Rep 2 Rh4 Clone Cells, ishFAN…
- GSM8867730 Rh4 Clone Cells, ishFANCM_SMC, Day 2, Rep 3 Rh4 Clone Cells, ishFAN…
- GSM8867731 Rh4 Clone Cells, ishFANCM, Day 2, Rep 1 Rh4 Clone Cells, ishFAN…
- GSM8867732 Rh4 Clone Cells, ishFANCM, Day 2, Rep 2 Rh4 Clone Cells, ishFAN…
- GSM8867733 Rh4 Clone Cells, ishFANCM, Day 2, Rep 3 Rh4 Clone Cells, ishFAN…
- GSM9805555 Rh4 Clone Cells, Parental, Rep1 Rh4 Clone Cells, Parent…
- GSM9805556 Rh4 Clone Cells, Parental, Rep2 Rh4 Clone Cells, Parent…
- GSM9805557 Rh4 Clone Cells, Parental, Rep3 Rh4 Clone Cells, Parent…
- GSM9805558 Rh4 Clone Cells, Treated IR24hrs, Rep1 Rh4 Clone Cells, Treate…
- GSM9805559 Rh4 Clone Cells, Treated IR24hrs, Rep2 Rh4 Clone Cells, Treate…
- GSM9805560 Rh4 Clone Cells, Treated IR24hrs, Rep3 Rh4 Clone Cells, Treate…
- GSE292876 FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [ChIP-Seq] 18 samples same disease briefing · shares fancm, pax3, rhabdomyosarcoma, foxo1-driven, oncogenic, required, program
- GSE286950 PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 16 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE279337 Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma 40 samples same disease briefing · shares pax3, rhabdomyosarcoma
- GSE300974 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [RNA-seq] 30 samples same disease briefing · shares rhabdomyosarcoma, rna-seq
- GSE240287 RNA-sequencing of matched samples from rhabdomyosarcoma samples, obtained before therapy and mid-treatment resection 18 samples same disease briefing · shares rhabdomyosarcoma, rna-seq
- GSE313525 TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma 6 samples same disease briefing · shares rhabdomyosarcoma, oncogenic
- GSE131309 Opposing genetic and immune mechanisms shape oncogenic programs in synovial sarcoma 4 samples same disease briefing · shares oncogenic, program
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.